Cannabis Daily News
Cannabis Daily News · page 2
- Cannabis Daily News
Cannabis News Today — Wednesday 20 May 2026: Virginia Governor Kills Sales Bill as DOT Holds Line on Transport Drug Testing
Wednesday’s dominant story is Virginia Governor Abigail Spanberger’s decision to veto legislation that would have created the state’s first licensed cannabis retail market, leaving personal possession legal and the unregulated market unaddressed for at least another year.
- Cannabis Daily News
Cannabis News Today — Tuesday 19 May 2026: FDA Backs Cannabis Pain Drug as Post-Rescheduling Wave Reaches States and Markets
The downstream effects of April’s federal rescheduling continued to accelerate on Monday.
- Cannabis Daily News
Cannabis News Today — Monday 18 May 2026: RICO Class Action Names Three US Operators as Canada Leads Germany’s Medical Cannabis Imports
A 320-page RICO complaint against three of America’s largest cannabis operators landed in insurance and legal analysis this morning, signalling the litigation risks that federal rescheduling may accelerate.
- Cannabis Daily News
Cannabis News Today — Friday 15 May 2026: Congress Fractures on Rescheduling as Delaware Court Extends Bankruptcy Protection to Cannabis
Congress pulled in opposite directions on cannabis on Thursday: the House Appropriations Committee voted to bar further federal rescheduling, even as the full chamber passed a bipartisan amendment giving veterans the right to discuss medical cannabis with their VA doctors.
- Cannabis Daily News
Cannabis News Today — Thursday 14 May 2026: Congress targets unregulated cannabinoids as operators race for Schedule III registration
Two threads dominated the past 24 hours in cannabis policy. The House Appropriations Committee moved to increase federal scrutiny of unregulated cannabinoid products, while state-licensed operators competed to file DEA applications under the 60-day Schedule III registration window.
- Cannabis Daily News
Cannabis News Today — Tuesday 12 May 2026: Federal rescheduling machinery shifts into gear as Cronos posts record quarter and Massachusetts repels rollback
Three and a half weeks after the Justice Department moved state-licensed medical cannabis to Schedule III, a cluster of practical consequences is landing simultaneously.
- Cannabis Daily News
Cannabis News Today — Friday 8 May 2026: Repeal Efforts Collapse as Industry Faces Fresh Legal and Strategic Tests
Repeal campaigns stall in Arizona as Idaho medical cannabis activists oversubscribe their ballot push, fresh research on legalisation arrests lands, and the industry’s medical-marketing claims and Tilray’s expansion playbook draw scrutiny.
- Markets & Stocks
Cannabis Stocks Today — Friday 8 May 2026: Mixed Session as WM Technology Gains 14%
BoC Cannabis Index closes +0.61% but breadth turns negative as 23 of 38 names fall; WM Technology surges 14% while REFI leads losers down 5%.
- Cannabis Daily News
Cannabis News Today — Thursday 7 May 2026: Rescheduling Pressure Builds as White House Sounds Potency Alarm
Today’s cannabis news is dominated by rescheduling momentum, with operators racing to secure DEA Schedule III status even as the White House raises fresh concerns over high-potency products, while the UK, Brazil and Idaho underline how rapidly access is broadening on multiple fronts.
- Markets & Stocks
Cannabis Stocks Today — Thursday 7 May 2026: Curaleaf Leads +9.4% as Sector Rallies
BoC Cannabis Index +1.67% on broad strength; Curaleaf +9.4% leads a 27-stock advance, IIPR -4.3% the day’s worst.
- Markets & Stocks
Cannabis Stocks Today — Wednesday 6 May 2026: Innovative Industrial Properties Leads +14.03% as Sector Rallies
BoC Cannabis Index gains +1.26% as Innovative Industrial Properties surges +14.03%, lifting US MSOs and ETFs in a synchronised cannabis rally.
- Cannabis Daily News
Cannabis News Today — Wednesday 6 May 2026: Federal Pressure Mounts as UK Hits Medical Manufacturing Milestone
Trump targets hemp products, DEA pushes medical cannabis operators toward Schedule III registration, a major lawsuit hits industry therapeutic claims, Curaleaf marks a UK manufacturing first, and Virginia’s adult-use sales bill awaits the governor’s signature.
